These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27852539)

  • 1. Microbiome alterations observed in liver diseases present opportunities for potential fecal transplantation.
    Heath RD; Mir F; Ibdah JA; Tahan V
    Turk J Gastroenterol; 2016 Nov; 27(6):495-498. PubMed ID: 27852539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction.
    Lechner S; Yee M; Limketkai BN; Pham EA
    Dig Dis Sci; 2020 Mar; 65(3):897-905. PubMed ID: 32020359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the gut-liver axis in liver disease.
    Wiest R; Albillos A; Trauner M; Bajaj JS; Jalan R
    J Hepatol; 2017 Nov; 67(5):1084-1103. PubMed ID: 28526488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the microbiota in the management of gastrointestinal and liver disease.
    Quigley EM; Monsour HP
    Rev Gastroenterol Peru; 2013; 33(2):139-44. PubMed ID: 23838941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intestinal bacteria involved in nutritional liver disease killed by phagotherapy: a new therapeutic target].
    Ciocan D; Cassard AM
    Med Sci (Paris); 2020 Apr; 36(4):310-312. PubMed ID: 32356701
    [No Abstract]   [Full Text] [Related]  

  • 6. Fecal transplant to mitigate hyperammonemia and hepatic encephalopathy in animal models.
    Kang DJ; Hylemon PB; Bajaj JS
    Ann Hepatol; 2015; 14(5):762-3. PubMed ID: 26256908
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrosis and the intestinal microbiome; a focus on chronic liver disease.
    Beraza N
    Curr Opin Pharmacol; 2019 Dec; 49():76-81. PubMed ID: 31670055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
    Brandl K; Schnabl B
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey on the developmental intestinal microbiota research in China: The history, funding, and frontiers of gut bacteria.
    Chen HM; Liu XW; Sun RJ; Fang JY
    J Dig Dis; 2015 Aug; 16(8):421-30. PubMed ID: 26215325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics in Pediatric Liver Disease.
    Miloh T
    J Clin Gastroenterol; 2015; 49 Suppl 1():S33-6. PubMed ID: 26447962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic Delivery of Fecal Biotherapy in Inflammatory Bowel Disease.
    Kerman DH
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):707-17. PubMed ID: 27633598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of fecal microbiota transplantation suitable for mainstream medicine.
    Khoruts A; Sadowsky MJ; Hamilton MJ
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):246-50. PubMed ID: 25460566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota and Energy Expenditure in Health and Obesity.
    Bakker GJ; Zhao J; Herrema H; Nieuwdorp M
    J Clin Gastroenterol; 2015; 49 Suppl 1():S13-9. PubMed ID: 26447957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to: " 'You know my name, but not my story' - Deciding on an accurate nomenclature for faecal microbiota transplantation": Intestinal microbiota transplantation: Naming a new paradigm.
    Khoruts A; Bajaj JS
    J Hepatol; 2020 Jun; 72(6):1213-1214. PubMed ID: 32197802
    [No Abstract]   [Full Text] [Related]  

  • 16. [Structure and function of intestinal microbiota in health and disease--130 years after Theodor Escherich].
    Meri S; de Vos W
    Duodecim; 2015; 131(22):2091-8. PubMed ID: 26749902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
    Berg D; Clemente JC; Colombel JF
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):781-95. PubMed ID: 25665875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering the gut microbiota to treat hyperammonemia.
    Shen TC; Albenberg L; Bittinger K; Chehoud C; Chen YY; Judge CA; Chau L; Ni J; Sheng M; Lin A; Wilkins BJ; Buza EL; Lewis JD; Daikhin Y; Nissim I; Yudkoff M; Bushman FD; Wu GD
    J Clin Invest; 2015 Jul; 125(7):2841-50. PubMed ID: 26098218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead.
    Borody T; Fischer M; Mitchell S; Campbell J
    Expert Rev Gastroenterol Hepatol; 2015; 9(11):1379-91. PubMed ID: 26414076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How our understanding of the microbiome has changed the way we look at liver diseases.
    Adolph TE; Effenberger M; Tilg H
    Biomark Med; 2018 Nov; 12(11):1203-1206. PubMed ID: 30444134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.